Averin Capital Acquisition Corp.
ACAA
Sync financial data to generate a health grade for this company.
Analytical Summary
Review the statement evidence below to form a view on ACAA.
4-Year Financial Trajectory
QuarterlyStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2025 10-Q ↗ |
|---|---|---|---|---|
| FCF / Net Income (x) |
-0.07x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.48x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
| Metric | Q2 FY2026 Jun 30, 2026 10-Q ↗ | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2025 10-Q ↗ |
|---|---|---|---|---|
| Return on Invested Capital (%) |
0.9%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
0.9%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
| Return on Capital (%) (%) |
-0.1%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-0.1%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — |
| Return on Common Equity (%) (%) |
-5.5%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-146%)
|
-5.5%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-146%)
|
— | — |
Secondary lens
Benchmark Lens
Compare ACAA against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare ACAA against peers after checking the statement evidence.
Compare ACAA with peers
Stack ACAA against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced yesterday